Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars

from BioSpace · host BioSpace

This week Lori, Greg and Tyler discuss AbbVie: how longtime CEO Richard Gonzalez navigated Humira's LOE, his victorious retirement announcement, and the future of biosimilars. Also discussed: Earlybird Health's $186m VC fund; and definitely not the IRA.

Episode metadata supplied by the publisher feed · Published Feb 28, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars

0:00 14:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioSpace?

This episode is 14 minutes long.

When was this BioSpace episode published?

This episode was published on February 28, 2024.

Can I download this BioSpace episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!